These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34635375)

  • 21. Rotavirus vaccine effectiveness in preventing hospitalizations due to gastroenteritis: a descriptive epidemiological study from Germany.
    Pietsch C; Liebert UG
    Clin Microbiol Infect; 2019 Jan; 25(1):102-106. PubMed ID: 29649603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance.
    Bawa Z; Elliot AJ; Morbey RA; Ladhani S; Cunliffe NA; O'Brien SJ; Regan M; Smith GE
    Clin Infect Dis; 2015 Jul; 61(1):77-85. PubMed ID: 25828997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.
    Orrico-Sanchez A; López-Lacort M; Pérez-Vilar S; Díez-Domingo J
    BMC Infect Dis; 2017 Apr; 17(1):267. PubMed ID: 28399824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report of the Third European Expert Meeting on Rotavirus Vaccination: Progress in rotavirus universal mass vaccination in Europe.
    Huppertz H; Borte M; Schuster V; Giaquinto C; Vesikari T
    Vaccine; 2014 Jul; 32(34):4243-8. PubMed ID: 24852720
    [No Abstract]   [Full Text] [Related]  

  • 25. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
    Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
    Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".
    Jit M; Mangen MJ; Melliez H; Yazdanpanah Y; Bilcke J; Salo H; Edmunds WJ; Beutels P
    Vaccine; 2010 Nov; 28(47):7457-9. PubMed ID: 20846529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis.
    Fathima P; Jones MA; Moore HC; Blyth CC; Gibbs RA; Snelling TL
    J Epidemiol; 2021 Aug; 31(8):480-486. PubMed ID: 32801278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The control of rotavirus gastroenteritis in the United States.
    Glass RI; Parashar U; Patel M; Tate J; Jiang B; Gentsch J
    Trans Am Clin Climatol Assoc; 2012; 123():36-52; discussion 53. PubMed ID: 23303967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Success ofrotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness.
    Solastie A; Leino T; Ollgren J
    Vaccine; 2020 May; 38(21):3766-3772. PubMed ID: 32280041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotavirus Infection in the Auckland Region After the Implementation of Universal Infant Rotavirus Vaccination: Impact on Hospitalizations and Laboratory Implications.
    McAuliffe GN; Taylor SL; Drinković D; Roberts SA; Wilson EM; Best EJ
    Pediatr Infect Dis J; 2018 Jan; 37(1):e1-e5. PubMed ID: 28746261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
    Reyes JF; Wood JG; Beutels P; Macartney K; McIntyre P; Menzies R; Mealing N; Newall AT
    Vaccine; 2017 Jan; 35(2):345-352. PubMed ID: 27916411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.
    Wilson SE; Rosella LC; Wang J; Renaud A; Le Saux N; Crowcroft NS; Desai S; Harris T; Bolotin S; Gubbay J; Deeks SL
    Vaccine; 2019 Apr; 37(17):2408-2414. PubMed ID: 30765171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotavirus gastroenteritis hospitalisations following introduction of vaccination, Canberra.
    David RL; Kirk MD
    Commun Dis Intell Q Rep; 2014 Mar; 38(1):E3-8. PubMed ID: 25409353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease.
    Harris JP; Jit M; Cooper D; Edmunds WJ
    Vaccine; 2007 May; 25(20):3962-70. PubMed ID: 17395343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid Declines in Age Group-Specific Rotavirus Infection and Acute Gastroenteritis Among Vaccinated and Unvaccinated Individuals Within 1 Year of Rotavirus Vaccine Introduction in England and Wales.
    Atchison CJ; Stowe J; Andrews N; Collins S; Allen DJ; Nawaz S; Brown D; Ramsay ME; Ladhani SN
    J Infect Dis; 2016 Jan; 213(2):243-9. PubMed ID: 26232438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
    Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
    Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
    Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Routine Rotavirus Vaccination in Germany: Evaluation Five Years After Its Introduction.
    Marquis A; Koch J
    Pediatr Infect Dis J; 2020 Jul; 39(7):e109-e116. PubMed ID: 32187139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.